Corporate & Investor Presentation

Leadership in OSA treatment with data applications ResMed myAir Avaalean ins and Aneroid Resivod о moskevat пократ Fiday, June y 91 Talmie 022 8 ResMed AirView™ ResMed ResMed 2014. ResMed AirSION Eugene, Judy Las ResMad AirNew Patients Training for HME Training for Sleep Lab Main Men Heme User-friendly, intuitive platform provides milestone accomplishments and motivation to patients, increasing therapy adherence, and improving sleep quality Focused on app enhancements to enable long-term adherence for life vs. short-term (e.g., app-based nudges) Clear-cut market leader with 4.0M U.S. patients registered to the myAir platform across the website and app Recently launched upgraded version: myAir 2.0 Key differentiators Large installed base with over 18.5M patient enrolled in our cloud-based software solution Seamless integration with ResMed devices enhances provider efficiency and improves patient monitoring through industry-leading remote diagnostic tools Increased data capture enables us to drive more personalized care to improve the patient experience Unlocking value for both patients and providers 16 2022 ResMed | Corporate & Investor Presentation - updated 27JAN22 ResMed

View entire presentation